Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Cleveland

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
Molecular Cell|April 30, 2003
Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 lossTroy A Baudino, Kirsteen H Maclean, Jennifer Brennan, et al.
Medchemcomm|June 28, 2016
Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitorsReji N Nair, Jitendra K Mishra, Fangzheng Li, et al.
Blood|July 22, 2008
Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHASteffan T Nawrocki, Jennifer S Carew, Kirsteen H Maclean, et al.
Blood|December 7, 2011
Mitochondrial dysfunction in ataxia-telangiectasiaYasmine A Valentin-Vega, Kirsteen H Maclean, Jacqueline Tait-Mulder, et al.
The Journal of Biological Chemistry|October 4, 2005
The inv(16) cooperates with ARF haploinsufficiency to induce acute myeloid leukemiaIsabel Moreno-Miralles, Ling Pan, Jennifer Keates-Baleeiro, et al.
Nature|December 22, 2007
Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosisMiguel A Sanjuan, Christopher P Dillon, Stephen W G Tait, et al.
Cancer Research|June 19, 2008
The novel polyamine analogue CGC-11093 enhances the antimyeloma activity of bortezomibJennifer S Carew, Steffan T Nawrocki, Venudhar K Reddy, et al.
Cell|August 7, 2012
Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant stateRobert J Rounbehler, Mohammad Fallahi, Chunying Yang, et al.
Blood|August 22, 2014
Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphomaAlexander Hoellein, Mohammad Fallahi, Stephanie Schoeffmann, et al.
Cancer Cell|May 17, 2005
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formationJonas A Nilsson, Ulrich B Keller, Troy A Baudino, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
Molecular Cell|April 30, 2003
Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 lossTroy A Baudino, Kirsteen H Maclean, Jennifer Brennan, et al.
Medchemcomm|June 28, 2016
Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitorsReji N Nair, Jitendra K Mishra, Fangzheng Li, et al.
Blood|July 22, 2008
Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHASteffan T Nawrocki, Jennifer S Carew, Kirsteen H Maclean, et al.
Blood|December 7, 2011
Mitochondrial dysfunction in ataxia-telangiectasiaYasmine A Valentin-Vega, Kirsteen H Maclean, Jacqueline Tait-Mulder, et al.
The Journal of Biological Chemistry|October 4, 2005
The inv(16) cooperates with ARF haploinsufficiency to induce acute myeloid leukemiaIsabel Moreno-Miralles, Ling Pan, Jennifer Keates-Baleeiro, et al.
Nature|December 22, 2007
Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosisMiguel A Sanjuan, Christopher P Dillon, Stephen W G Tait, et al.
Cancer Research|June 19, 2008
The novel polyamine analogue CGC-11093 enhances the antimyeloma activity of bortezomibJennifer S Carew, Steffan T Nawrocki, Venudhar K Reddy, et al.
Cell|August 7, 2012
Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant stateRobert J Rounbehler, Mohammad Fallahi, Chunying Yang, et al.
Blood|August 22, 2014
Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphomaAlexander Hoellein, Mohammad Fallahi, Stephanie Schoeffmann, et al.
Cancer Cell|May 17, 2005
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formationJonas A Nilsson, Ulrich B Keller, Troy A Baudino, et al.
Pageof 16